.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Medtronic
Queensland Health
Dow
QuintilesIMS
Cerilliant
Teva
Baxter
Boehringer Ingelheim
Covington

Generated: December 15, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: bupropion hydrobromide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5810-077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-07)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5810-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-30)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5811-077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5811-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-30)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5812-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDAValeant Pharmaceuticals North America LLC0187-5812-077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDASTAT RX USA LLC16590-922-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-922-90)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDASTAT RX USA LLC16590-922-6060 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-922-60)
Valeant Pharms NorthAPLENZINbupropion hydrobromideTABLET, EXTENDED RELEASE;ORAL022108NDASTAT RX USA LLC16590-922-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (16590-922-30)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Teva
Queensland Health
Healthtrust
Moodys
Dow
Accenture
Merck
Cerilliant
US Department of Justice

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot